Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 4/2004

01-12-2004 | Original Article

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate

Authors: Mats Hardling, MD, Yuan Wei, Lars Palmqvist, Birgitta Swolin, Dick Stockelberg, Bengt Gustavsson, Kerstin Ekeland-Sjöberg, Hans Wadenvik, Anne Ricksten

Published in: Medical Oncology | Issue 4/2004

Login to get access
Metadata
Title
Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate
Authors
Mats Hardling, MD
Yuan Wei
Lars Palmqvist
Birgitta Swolin
Dick Stockelberg
Bengt Gustavsson
Kerstin Ekeland-Sjöberg
Hans Wadenvik
Anne Ricksten
Publication date
01-12-2004
Publisher
Humana Press
Published in
Medical Oncology / Issue 4/2004
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1385/MO:21:4:349

Other articles of this Issue 4/2004

Medical Oncology 4/2004 Go to the issue

Original Article

Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer

BookReview

Book review

Letter

Acute leukemia in a patient with ocular melanoma

BookReview

Book review

Original Article

Long-term survivors in myelodysplastic syndromes

Case

Epithelioid sarcoma of vulva

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits